Ancor Plus Tablet 2.5mg+6.25mg

Presentation:

Ancor Plus-2.5 Tablet: Each film-coated tablet contains Bisoprolol Fumarate USP 2.5 mg and Hydrochlorothiazide BP 6.25 mg.

Ancor Plus-5 Tablet: Each film-coated tablet contains Bisoprolol Fumarate USP 5 mg and Hydrochlorothiazide BP 6.25 mg.

Indications:

Ancor Plus is indicated for the management of hypertension.

Dosage & Administration:

The initial dose is 2.5 mg/6.25 mg once daily. Subsequent titration (14 day intervals) may be carried out with Ancor Plus tablets

up to the maximum recommended dose 20 mg/12.5 mg once daily, as appropriate.

Therapy Guided by Clinical Effect: A patient whose blood pressure is not adequately controlled with 2.5-20 mg Bisoprolol daily may

instead be given Ancor Plus. Patients whose blood pressures are adequately controlled with 50 mg of Hydrochlorothiazide daily, but

who experience significant potassium loss with this regimen, may achieve similar blood pressure control without electrolyte

disturbance if they are switched to Ancor Plus.

Replacement Therapy: The combination may be substituted for the titrated individual components.

Cessation of Therapy: If withdrawal of Ancor Plus therapy is planned, it should be achieved gradually over a period of about 2

weeks. Patients should be carefully observed.

Contrainidications:

It is contraindicated in patients in cardiogenic shock, overt cardiac failure, second or third degree AV block, marked sinus

bradycardia, anuria and hypersensitivity to either component of this product or to other sulfonamide-derived drugs.

Warning & Precautions:

Hyperuricemia or acute gout may be precipitated in certain patients receiving thiazide diuretics. Warning signs or symptoms of

fluid and electrolyte imbalance include dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or

cramps, muscular fatigue, hypotension, oliguria, tachycardia and gastrointestinal disturbances such as nausea and vomiting.

Hypokalemia may develop.

Side effects:

Generally well-tolerated. Most side effects are mild and transient. The common side effects fatigue, dizziness, headache,

bradycardia, peripheral ischemia, palpitations, rhythm disturbances, claudication, orthostatic hypotension, diarrhoea,

constipation, nausea, dyspepsia, rhinitis, pharyngitis etc.

Drug interaction:

This combination drug may potentiate the action of other antihypertensive agents when used concomitantly. This combination drug

should not be combined with other beta-blocking agents. Patients receiving catecholamine-depleting drugs, such as reserpine or

guanethidine, should be closely monitored because the added beta-adrenergic blocking action of Bisoprolol may produce excessive

reduction of sympathetic activity. This combination should be used with caution when myocardial depressants or inhibitors of AV

conduction, such as certain calcium antagonists verapamil and benzothiazepine diltiazem classes or anti-arrhythmic agents, such as

disopyramide, are used concurrently. Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease

heart rate.

Use in special groups:

Use in Pregnancy: Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. This combination

should be used during pregnancy only if the potential benefit justifies the risk to the fetus.

Use in Nursing Mothers: Bisoprolol alone or in combination with Hydrochlorothiazide has not been studied in nursing mothers.

Packing:

Ancor Plus-2.5 Tablet: Each box contains 30 tablets in alu-alu blister pack.

Ancor Plus-5 Tablet: Each box contains 30 tablets in alu-alu blister pack.